COX-2 inhibition and the prevention of gastric cancer.
Lee
Dong-Soo
DS
Moss
Steven F
SF
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018890:Chemoprevention / Q000379:methods; D051546:Cyclooxygenase 2 / Q000009:adverse effects / Q000378:metabolism*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D005260:Female; D005753:Gastric Mucosa / Q000187:drug effects / Q000473:pathology; D006801:Humans; D008297:Male; D011379:Prognosis; D018570:Risk Assessment; D013274:Stomach Neoplasms / Q000201:enzymology* / Q000517:prevention & control*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D051546:Cyclooxygenase 2